Wockhardt Limited (BOM:532300)
India · Delayed Price · Currency is INR 1,811.45
-18.90 (-1.03%)
At close: Jul 10, 2026
Wockhardt Market Cap
Wockhardt has a market cap or net worth of 301.34 billion as of July 13, 2026. Its market cap has increased by 9.91% in one year.
Market Cap
301.34B
Enterprise Value
319.95B
Revenue
33.73B
Ranking
n/a
PE Ratio
141.47
Stock Price
1,811.45
Market Cap Chart
Since February 21, 2001, Wockhardt's market cap has increased from 17.40B to 301.34B, an increase of 1,631.47%. That is a compound annual growth rate of 11.88%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 10, 2026 | 294.22B | 25.20% |
| Dec 31, 2025 | 235.00B | 2.08% |
| Dec 31, 2024 | 230.20B | 276.45% |
| Dec 29, 2023 | 61.15B | 90.30% |
| Dec 30, 2022 | 32.13B | -29.77% |
| Dec 31, 2021 | 45.75B | -24.44% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Abbott India | 576.39B |
| GlaxoSmithKline Pharmaceuticals | 412.59B |
| J. B. Chemicals & Pharmaceuticals | 391.39B |
| Rubicon Research | 231.84B |
| Granules India | 220.43B |
| AstraZeneca Pharma India | 203.10B |
| Caplin Point Laboratories | 196.52B |
| Jubilant Pharmova | 152.20B |